Published in Vaccine Weekly, November 8th, 2000
"We compared the immunogenicity of two preparations of a peptide derived from the Plasmodium berghei circumsporozoite protein, which is expressed on the surface of the preerythrocytic stage of the malaria parasite (PbCS242-310)," stated Vincent Brossard and colleagues from the Institute of Biochemistry, Epalinges. "The peptide was synthesized using a Fmoc/tBu solid phase strategy with a HOBT/DIPC activation, cleaved with the Barany's emulsion, precipitated in ether, purified by RP-HPCL, and folded."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly